Onsdag 10 Juni | 12:00:00 Europe / Stockholm

Kalender

Est. tid*
2027-02-05 08:30 Bokslutskommuniké 2026
2026-11-13 07:00 Kvartalsrapport 2026-Q3
2026-08-24 07:00 Kvartalsrapport 2026-Q2
2026-05-25 - Årsstämma
2026-05-25 - Kvartalsrapport 2026-Q1
2026-04-13 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2026-04-13 - Extra Bolagsstämma 2026
2026-02-06 - Bokslutskommuniké 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-08-04 - Extra Bolagsstämma 2025
2025-07-11 - Kvartalsrapport 2025-Q2
2025-04-10 - Årsstämma
2025-04-10 - Kvartalsrapport 2025-Q1
2025-04-04 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2025-02-05 - Bokslutskommuniké 2024
2024-10-25 - Kvartalsrapport 2024-Q3
2024-07-12 - Kvartalsrapport 2024-Q2
2024-05-22 - Extra Bolagsstämma 2024
2024-04-24 - Kvartalsrapport 2024-Q1
2024-04-10 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2024-04-09 - Årsstämma
2024-02-09 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2023-05-02 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-04-29 - Kvartalsrapport 2022-Q1
2022-04-05 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2022-04-04 - Årsstämma
2022-02-11 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-07-16 - Kvartalsrapport 2021-Q2
2021-05-11 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2021-05-10 - Årsstämma
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-19 - Bokslutskommuniké 2020
2020-10-23 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-04-24 - Kvartalsrapport 2020-Q1
2020-04-03 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2020-04-02 - Årsstämma
2020-03-10 - Extra Bolagsstämma 2020
2020-02-07 - Bokslutskommuniké 2019
2019-10-25 - Kvartalsrapport 2019-Q3
2019-07-19 - Kvartalsrapport 2019-Q2
2019-05-07 - Extra Bolagsstämma 2019
2019-04-26 - Kvartalsrapport 2019-Q1
2019-04-09 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2019-04-08 - Årsstämma
2019-02-08 - Bokslutskommuniké 2018
2018-10-26 - Kvartalsrapport 2018-Q3
2018-07-20 - Kvartalsrapport 2018-Q2
2018-04-27 - Kvartalsrapport 2018-Q1
2018-04-10 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2018-04-09 - Årsstämma
2018-02-23 - Bokslutskommuniké 2017
2017-11-10 - Kvartalsrapport 2017-Q3
2017-08-18 - Kvartalsrapport 2017-Q2
2017-05-23 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2017-05-22 - Årsstämma
2017-05-15 - Kvartalsrapport 2017-Q1
2017-02-24 - Bokslutskommuniké 2016
2017-02-20 - Extra Bolagsstämma 2017
2016-11-04 - Kvartalsrapport 2016-Q3
2016-08-19 - Kvartalsrapport 2016-Q2
2016-05-25 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2016-05-24 - Årsstämma
2016-05-17 - Kvartalsrapport 2016-Q1
2016-02-23 - Bokslutskommuniké 2015
2015-11-06 - Kvartalsrapport 2015-Q3
2015-08-21 - Kvartalsrapport 2015-Q2
2015-05-07 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2015-05-06 - Årsstämma
2015-05-06 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-11-07 - Kvartalsrapport 2014-Q3
2014-08-22 - Kvartalsrapport 2014-Q2
2014-06-04 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2014-06-03 - Årsstämma
2014-05-09 - Kvartalsrapport 2014-Q1
2014-02-21 - Bokslutskommuniké 2013
2014-02-12 - Extra Bolagsstämma 2014
2013-11-06 - Kvartalsrapport 2013-Q3
2013-08-22 - Kvartalsrapport 2013-Q2
2013-05-03 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2013-05-03 - Kvartalsrapport 2013-Q1
2013-05-02 - Årsstämma
2013-04-03 - Extra Bolagsstämma 2013
2013-02-21 - Bokslutskommuniké 2012
2012-11-21 - Kvartalsrapport 2012-Q3
2012-08-22 - Kvartalsrapport 2012-Q2
2012-06-04 - Årsstämma
2012-05-04 - Kvartalsrapport 2012-Q1
2012-02-21 - Bokslutskommuniké 2011
2011-11-21 - Kvartalsrapport 2011-Q3
2011-08-22 - Kvartalsrapport 2011-Q2
2011-07-20 - Split EPIS B 6:1
2011-06-30 - Årsstämma
2011-05-21 - Kvartalsrapport 2011-Q1
2011-05-13 - Extra Bolagsstämma 2011
2011-05-02 - Kvartalsrapport 2011-Q1
2011-02-18 - Bokslutskommuniké 2010
2010-08-30 - Extra Bolagsstämma 2010

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Episurf Medical är ett fastighetsbolag med exponering mot en diversifierad portfölj av fastighetstillgångar. Bolaget har som mål att skapa värdetillväxt genom förvärv och förvaltning av nordiska fastigheter. Bolaget har även en medicinteknisk verksamhet som bygger på ett individanpassat implantat, Episealer® och tillhörande kirurgiska instrument, vilka används för att behandla broskskador i leder. Episurf Medicals huvudkontor ligger i Stockholm, Sverige.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-06-05 16:30:00

Episurf Medical AB (publ) (Nasdaq: EPIS B) has entered into an agreement to acquire a mixed portfolio of 30 properties with a total agreed property value of SEK 920 mn, with a possible deferred consideration of SEK 25 mn. Closing is conditional on financing being secured and is expected to take place during the second or third quarter of 2026.

"We have now signed deals worth over SEK 5 billion and reached the halfway point towards our full-year target of SEK 10 billion. We are building a Nordic real estate platform with stable cash flows, and we are maintaining a strong pace."

- Jens Andersson, CEO, Episurf Medical

The acquisition in brief

Episurf has entered into an agreement to acquire all shares in Grännäs Fastigheter Holding AB, reg. no. 559572-2470, and Goldcup 39848 AB, reg. no. 559585-9330, from Livi Fastigheter AB.

The property portfolio comprises 30 properties and constitutes a mixed portfolio of residential properties and LSS housing. The lettable area amounts to approximately 51,000 sqm.

The total agreed property value amounts to SEK 920 mn, with a possible deferred consideration of SEK 25 mn based on the occupancy rate at closing.

Payment of the purchase price

The purchase price is financed through an issue of B-shares of SEK 200 mn at a price of SEK 0.10 per B-share, a convertible loan of SEK 66.5 mn with a 24-month maturity and interest of STIBOR + 1.75 percent, and financing from banks and credit institutions.

The conversion price is determined by the time at which conversion is called: SEK 0.11 per B-share during the first six months, SEK 0.12 per B-share during the following twelve months and SEK 0.13 per B-share during the final six months. The buyer is entitled to call for conversion during the final six-month period.

Dilution

The issue of B-shares and conversion of the convertible loan may result in dilution for existing shareholders of up to approximately 59 percent based on the current number of registered shares. Calculated on all issued and contracted shares prior to the acquisition (fully diluted basis), the dilution amounts to approximately 7 percent.

Background and rationale

On 30 December 2025, Episurf's board of directors announced that the Company had decided to acquire property companies to broaden its operations and strengthen its financial position. Episurf has since entered into agreements to acquire Frusipe Intressenter Target 1 AB, KlaraBo Empire Holding AB, Mofast Invest II AB, a property portfolio from Botrygg AB, a property portfolio from Lilium, two smaller properties from HanssonGruppen and a property portfolio from Setune Assets AB in Uppsala.

With the acquisition of the property portfolio from Livi Fastigheter, Episurf continues to build its Nordic property platform with a focus on cash flow and return. Based on already signed property acquisitions, the annual rental income of Episurf's property segment is expected, on a pro forma basis following the acquisition, to increase from approximately SEK 357 mn to approximately SEK 439 mn, and total property assets from approximately SEK 4,319 mn to approximately SEK 5,264 mn.

Key figures for the property portfolio

The property portfolio has an agreed property value of SEK 920 mn, a lettable area of approximately 51,000 sqm and net operating income (NOI) of SEK 57 mn, corresponding to an NOI yield of approximately 6.2 percent. Annual rental income amounts to approximately SEK 77.7 mn. The occupancy rate amounts to approximately 95%.

For further information, please contact:

Jens Andersson, CEO, Episurf Medical

Email: jens.andersson@episurf.com

About Episurf Medical

Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The Company's objective is to create value growth through the acquisition and management of Nordic properties. The Company also has a medical technology operation based on the individualized implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. Episurf Medical's head office is in Stockholm, Sweden.

This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication, through the agency of the contact person set out above, at 16:30 CET on 5 June 2026.

THIS PRESS RELEASE HAS BEEN PUBLISHED IN SWEDISH AND ENGLISH. IN THE EVENT OF ANY DISCREPANCY BETWEEN THE LANGUAGE VERSIONS, THE SWEDISH VERSION SHALL PREVAIL.